You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 7,084,130


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,084,130
Title:Intraocular irrigating solution having improved flow characteristics
Abstract:Improved intraocular irrigating solutions are described. The solutions have enhanced viscosities that reduce the risk of damage to intraocular surgical procedures by reducing the turbulence of the solutions and dampening the movement of tissue fragments and air bubbles. The solutions preferably also have modified surface tensions that more closely resemble the surface tension of the aqueous humor.
Inventor(s): Shah; Mandar V. (Arlington, TX), Boukhny; Mikhail (Laguna Niguel, CA), Garner; William H. (Southlake, TX), Markwardt; Kerry L. (Mansfield, TX), Doshi; Uday (Randolph, NJ)
Assignee: Alcon, Inc. (Hunenberg, CH)
Application Number:10/240,449
Patent Claim Types:
see list of patent claims
Composition; Formulation; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,084,130: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The United States Patent 7,084,130, like any other patent, has a specific scope and set of claims that define its boundaries and protections. This article delves into the details of this patent, exploring its claims, the patent landscape, and relevant legal and practical considerations.

What is a Patent?

Before diving into the specifics of the United States Patent 7,084,130, it is essential to understand what a patent is. A patent is a form of intellectual property that grants the owner the exclusive right to make, use, sell, and distribute an invention for a certain period, usually 20 years from the filing date of the patent application[2].

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is responsible for granting patents and registering trademarks. The USPTO ensures that patents meet the criteria of novelty, non-obviousness, and usefulness[2].

Patent 7,084,130: Overview

To analyze the scope and claims of United States Patent 7,084,130, one must first identify the invention it covers. However, since the specific details of this patent are not provided in the sources, we will discuss the general process and considerations involved in analyzing any patent.

Invention Type

Patents can be categorized into various fields such as electrical engineering, mechanical engineering, chemistry, and more. For instance, in 2018, electrical and mechanical engineering patents made up about 60% of the patents granted by the USPTO[4].

Claims

The claims section of a patent is crucial as it defines the scope of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. The Patent Claims Research Dataset by the USPTO provides detailed information on claims from US patents, including claim-level statistics and document-level statistics[3].

Independent and Dependent Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.

Patent Scope

The scope of a patent is determined by its claims. A broader scope means the patent covers a wider range of variations of the invention, while a narrower scope limits the protection to a more specific embodiment.

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA) or other extensions. This is relevant when analyzing patents within the same family, as seen in the case of In re Cellect LLC[1].

Patent Term Adjustment (PTA)

PTA is granted for delays during the prosecution process caused by the USPTO. This adjustment can affect the expiration date of the patent. In the context of ODP, any analysis or determination should be based on the adjusted expiration date of the patent[1].

Legal Considerations

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. These disclaimers involve the patent owner disclaiming the term of the later patent to the extent it extends beyond the term of the earlier patent. The Federal Circuit has held that a patent term extension under certain sections of the patent law is not foreclosed by a terminal disclaimer[1].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could impact how patent disputes are handled, especially for smaller inventors and companies. This court would aim to provide a more streamlined and cost-effective process for resolving patent disputes[5].

Practical Considerations

Patent Landscape

Understanding the patent landscape involves analyzing the existing patents in the same field. This helps in identifying potential infringement risks and opportunities for innovation. For example, the rise in electrical engineering patents, particularly in computer technology and digital communication, indicates a vibrant and competitive field[4].

Economic Impact

Patents have a significant economic impact. They encourage innovation by providing a temporary monopoly, which can lead to investment and job creation. The USPTO's economic research datasets provide insights into the economic trends and impact of patents[3].

Key Takeaways

  • Patent Claims: The claims section is critical in defining the scope of the invention.
  • ODP: Prevents securing a second, later-expiring patent for the same invention.
  • PTA: Adjusts the patent term for delays caused by the USPTO.
  • Terminal Disclaimers: Used to overcome ODP rejections by disclaiming the extended term.
  • Patent Landscape: Understanding existing patents in the field is crucial for innovation and risk management.
  • Economic Impact: Patents drive innovation and have significant economic benefits.

FAQs

What is the purpose of the claims section in a patent?

The claims section defines the scope of the invention, distinguishing it from prior art and specifying what is protected by the patent.

How does Obviousness-Type Double Patenting (ODP) affect patents?

ODP prevents an inventor from securing a second, later-expiring patent for an invention already covered by an earlier patent, ensuring that the inventor does not extend the patent term indefinitely.

What is Patent Term Adjustment (PTA)?

PTA is an adjustment to the patent term granted for delays during the prosecution process caused by the USPTO, extending the patent term accordingly.

Why are terminal disclaimers used in patent law?

Terminal disclaimers are used to overcome ODP rejections by disclaiming the term of the later patent to the extent it extends beyond the term of the earlier patent.

What is the proposed role of a small claims patent court?

A small claims patent court would provide a streamlined and cost-effective process for resolving patent disputes, particularly beneficial for smaller inventors and companies.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims Research Dataset, USPTO, August 28, 2017.
  4. Invention: U.S. and Comparative Global Trends, National Science Foundation, January 15, 2020.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,084,130

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,084,130

PCT Information
PCT FiledDecember 11, 2001PCT Application Number:PCT/US01/48094
PCT Publication Date:June 27, 2002PCT Publication Number: WO02/49614

International Family Members for US Patent 7,084,130

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 459337 ⤷  Subscribe
Australia 2002239601 ⤷  Subscribe
Australia 3960102 ⤷  Subscribe
Brazil 0116353 ⤷  Subscribe
Canada 2431368 ⤷  Subscribe
Cyprus 1110703 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.